1. Home
  2. GDTC vs MIND Comparison

GDTC vs MIND Comparison

Compare GDTC & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • MIND
  • Stock Information
  • Founded
  • GDTC 2018
  • MIND 1987
  • Country
  • GDTC Singapore
  • MIND United States
  • Employees
  • GDTC N/A
  • MIND N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • GDTC Health Care
  • MIND Industrials
  • Exchange
  • GDTC Nasdaq
  • MIND Nasdaq
  • Market Cap
  • GDTC 33.4M
  • MIND 30.7M
  • IPO Year
  • GDTC 2023
  • MIND 1994
  • Fundamental
  • Price
  • GDTC $2.37
  • MIND $6.86
  • Analyst Decision
  • GDTC Buy
  • MIND
  • Analyst Count
  • GDTC 1
  • MIND 0
  • Target Price
  • GDTC $5.00
  • MIND N/A
  • AVG Volume (30 Days)
  • GDTC 24.9K
  • MIND 455.8K
  • Earning Date
  • GDTC 01-01-0001
  • MIND 12-10-2024
  • Dividend Yield
  • GDTC N/A
  • MIND N/A
  • EPS Growth
  • GDTC N/A
  • MIND N/A
  • EPS
  • GDTC N/A
  • MIND 6.61
  • Revenue
  • GDTC $330,254.00
  • MIND $45,197,000.00
  • Revenue This Year
  • GDTC $14.71
  • MIND $22.98
  • Revenue Next Year
  • GDTC N/A
  • MIND $10.18
  • P/E Ratio
  • GDTC N/A
  • MIND $0.97
  • Revenue Growth
  • GDTC N/A
  • MIND 41.23
  • 52 Week Low
  • GDTC $1.20
  • MIND $3.05
  • 52 Week High
  • GDTC $5.50
  • MIND $7.39
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 45.29
  • MIND 91.35
  • Support Level
  • GDTC $2.43
  • MIND $5.55
  • Resistance Level
  • GDTC $3.00
  • MIND $6.47
  • Average True Range (ATR)
  • GDTC 0.41
  • MIND 0.43
  • MACD
  • GDTC -0.03
  • MIND 0.34
  • Stochastic Oscillator
  • GDTC 21.60
  • MIND 95.33

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: